Shortage reports
Actual shortage:
4 (1%)
Anticipated shortage:
0 (0%)
Avoided shortage:
40 (10%)
Resolved:
354 (89%)
398
Discontinuation Reports
To be discontinued:
2 (9%)
Discontinued:
21 (91%)
Reversed:
0 (0%)
23
102 (24%)
1 (17%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-20 | 41546 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-30 | 41543 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-06-12 | 2019-07-05 | 86505 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-05 | 2021-12-09 | 146697 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Avoided shortage | 2024-09-25 | 2024-10-03 | 238527 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-06-02 | 2021-11-30 | 140229 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-23 | 2025-01-07 | 240919 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-05-31 | 2024-09-11 | 229320 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-07-24 | 2025-12-17 | 263466 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-06-04 | 2025-07-17 | 259451 |
| SYNALAR OINTMENT 0.025% | 0.025% | OINTMENT | Resolved | 2017-03-17 | 2017-06-06 | 3283 |
| TIAZAC XC | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-07-25 | 2025-10-08 | 263524 |
| TIAZAC XC | 240MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2019-09-10 | 2019-09-13 | 93532 |
| TIAZAC XC | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-07-25 | 2025-09-24 | 263521 |
| TIAZAC XC | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-19 | 2018-11-09 | 64999 |
| TOPICORT | 0.25% | OINTMENT | Resolved | 2023-11-23 | 2023-12-15 | 211247 |
| TOPICORT | 0.25% | CREAM | Resolved | 2018-06-29 | 2018-07-09 | 53240 |
| TOPICORT | 0.05% | CREAM | Resolved | 2023-11-23 | 2023-12-06 | 211250 |
| TOPICORT | 0.05% | CREAM | Resolved | 2023-11-23 | 2024-02-22 | 211244 |
| TOPICORT | 0.05% | CREAM | Resolved | 2023-08-23 | 2023-10-26 | 202719 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| BENZAMYCIN | 3% 5% | GEL | To be discontinued | 2026-01-20 | 2026-01-20 | 276371 |
| CARBOLITH | 150MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-23 | 247417 |
| CARBOLITH | 600MG | CAPSULE | Discontinued | 2025-01-10 | 2025-01-10 | 247420 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247352 |
| CARBOLITH | 300MG | CAPSULE | Discontinued | 2025-01-09 | 2025-01-09 | 247345 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| EMERADE | 0.5MG | SOLUTION | Discontinued | 2025-12-19 | 2025-12-20 | 274745 |
| EMERADE | 0.3MG | SOLUTION | Discontinued | 2025-12-19 | 2025-12-20 | 274742 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2025-04-15 | 212799 |
| MANERIX | 150MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 246998 |
| MANERIX | 300MG | TABLET | Discontinued | 2025-01-07 | 2025-01-08 | 247005 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | To be discontinued | 2025-11-18 | 2025-11-18 | 272123 |